Bio-ReCell is pleased to announce a new distribution partnership with Api Asia Ltd., significantly expanding the company’s presence across the Asia-Pacific region.
Through this agreement, Api Asia will represent Bio-ReCell technologies in South Korea, Japan, Taiwan, Thailand, Vietnam, Australia, New Zealand, Indonesia, Malaysia, the Philippines, and Singapore, providing researchers and organizations throughout the region with improved access to our innovative cell processing technologies.
The partnership follows Bio-ReCell’s recent expansion in India through collaborations with Ross Biotech, Cytocare, and Cell Bioasis, further strengthening the company’s presence in one of the world’s most dynamic biotechnology regions.
Asia-Pacific continues to play an increasingly important role in advancing biotechnology, regenerative medicine, and cell therapy development. With growing investment in life sciences infrastructure, translational research, and advanced therapeutic technologies, the region represents a key strategic focus for Bio-ReCell’s international growth.
Expanding our presence across Asia-Pacific is an important milestone for Bio-ReCell. The region is home to some of the world’s most innovative research institutions, biotechnology companies, and advanced therapy developers. Through our partnership with Api Asia, we look forward to supporting a growing community of researchers working to advance the future of cell-based technologies.
With this expansion, Bio-ReCell technologies are now available across an increasingly broad international network, supporting researchers, biotechnology companies, and translational teams around the world.
Interested in Representing Bio-ReCell?
Bio-ReCell continues to expand its global distributor network and is actively seeking partners who share its commitment to scientific innovation and customer success.
Contact us at sales@bio-recell.com to explore partnership opportunities.